Svaren, PhD, J. Activation of XBP1s Attenuates Disease Severity in Models of Proteotoxic Charcot-Marie-Tooth Type 1B.
Touvier, T., Veneri, F. A., Claessens, A., Ferri, C., Mastrangelo, R., Sorgiati, N., Bianchi, F., Valenzano, S., Del Carro, U., Rivellini, C., Duong, P., Shy, M. E., Kelly, J. W., Svaren, J., Wiseman, R. L., & D’Antonio, M. (2025). Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B. Brain : a journal of neurology, 148(6), 1978–1993. https://doi.org/10.1093/brain/awae407